What are the Plans and Implications for Keytrud...

By Rene Pretorius

June 9, 2025

Alvotech, a global biotech specializing in biosimilars, and Dr. Reddy’s Laboratories, an Indian pharmaceutical leader, have announced a global collaboration to co-develop, manufacture, and commercialize a biosim...
The Case for Transparency in Peer Review: Enhancing Scientific Integrity and ...
Quantifying EU Medicine Access Challenges
Blinatumomab Benefit Assessment for ALL and Health Economics
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
NICE HealthTech Reforms: Accelerating Digital Innovation in NHS and Global He...
Tolebrutinib MS Analysis: Evaluating Economic Impact in SPMS
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...
US Argentina WHO Withdrawal: A Shift in Global Health Governance
EU Patent Licensing Framework: Enhancing Crisis Management in the EU
South Africa Health Reform: A Critical Examination of Universal Coverage Prop...
EU Establishes Expert Panel for Orphan Paediatric Devices
Another GLP-1 Drug Access Model: Will a Co-Pay Cap Revolutionize Affordability?